Pietra et al, 2016.
Human natural killer cells: news in the therapy of solid tumors and high risk leukemias
Cancer Immunol Immunother.
Cancer Immunol Immunother.
von Lilienfeld-Toal et al, 2010.
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked
Cancer Immunol Immunother.
Pahl et al, 2013.
Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity
Cancer Immunol Immunother.